Home » Archive

Articles tagged with: electronic health records

Columns, Stats4Good »

[2 Oct 2023 | No Comment | ]

Bhramar Mukherjee of the University of Michigan was recently honored with the 2023 Karl E. Peace Award for Outstanding Statistical Contributions for the Betterment of Society, recognizing her commitment to and accomplishments in biostatistics on a global scale.

Departments, Featured, Meetings »

[1 Dec 2022 | Comments Off on Successful JSM 2023 Program Requires You | ]
Successful JSM 2023 Program Requires You

JSM 2023 Program Committee members put together more than 200 invited sessions on a broad range of topics in statistics and data science. Now, it’s time to fill out the rest of the program with your help.

Additional Features »

[1 Jun 2021 | Comments Off on Panel Provides Insights on Real-World Evidence in Health Care | ]

Real-world data (RWD) can come from a variety of sources, including claims, electronic health records, biobanks, genomics tests, and imaging modalities. Increasingly, it is coming from digital data through electronic health and mobile health modalities. Recent events have pushed innovation in the use of RWD to maximize the value of real-world evidence in an era of big data, data science, and artificial intelligence.

A Statistician's Life, Celebrating Hispanic Heritage Month »

[1 Sep 2020 | Comments Off on Miguel Marino | ]

As an associate professor of biostatistics at Oregon Health & Science University, Miguel Marino’s work earned him recognition in 2020 when he was selected by the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar.

Additional Features »

[1 Feb 2019 | Comments Off on Center for Clinical Epidemiology and Biostatistics to Hold Conference on Electronic Health Records | ]

The Center for Clinical Epidemiology and Biostatistics 12th Annual UPENN Conference on Statistical Issues in Clinical Trials will be held April 17.

Additional Features »

[2 Jan 2019 | Comments Off on NISS-Merck-HPSS Meet-Up Focuses on RWD | ]

RWD and its applications in the pharmaceutical industry was the topic of the fourth virtual meet-up sponsored by the National Institute of Statistical Sciences and Merck and co-sponsored by the ASA’s Health Policy Statistics Section for the first time this year. Big data, real-world data, and observational data have become ubiquitous and essential components of the drug development and commercialization process.